Storage and handling
Tamper resistant for your protection. Use only if safety seal is intact.
Tamper resistant for your protection. Use only if safety seal is intact.
Drug Facts
____________________________________________________________________________________________________________
HPUS active ingredients: Adenosinum cyclophosphoricum, Adrenalinum, Adrenocorticotrophin (30X), Allium cepa, Alnus serrulata, Carduus benedictus, Cichorium intybus, Cortisone aceticum, Dolichos pruriens, Euphrasia officinalis, Galphimia glauca, Histaminum hydrochloricum,Juglans cinerea, Kali muriaticum, Mucosa nasalis suis, Nasturtium aquaticum, Natrum muriaticum, Rhus tox, RNA, Sabadilla, Sassafras officinale.
Equal volumes of each ingredient in 12X, 30X, and 1LM.
Uses
for temporary relief of allergy symptoms commonly
experienced in AL, AR, DC, DE, FL, GA, KY, LA, MD, MS, NC,
SC, TN, VA, WV: █ itchy, watery eyes █ runny nose █ sneezing
█ sore throat █ sinus congestion █ cough █ stuffy nose █ fatigue
█ itchy, irritated skin █ hoarseness █ headache.
Warnings
Stop use and consult a physician if symptoms worsen or
persist for more than 7 days.
If pregnant or breast-feeding, ask a healthcare professional
before use.
Keep out of reach of children. In case of overdose, get
medical help or contact a Poison Control Center immediately.
Directions:
█ Initially, depress pump until
primed.
█ Spray one dose directly into
mouth.
█ Adults: 3 sprays 3 times per
day.
█ Children ages 6-12: 2 sprays 3
times per day.
█ Consult a physician for use in
children under 6 years of age.
█ Use additionally as needed, up
to 6 times per day
Tamper resistant for your protection. Use only if safety seal is intact.
Bio-Energetically Enhanced™ pure
water, citrus extract* (ascorbic
acid, citric acid, citrus aurantium
amara fruit extract, citrus
aurantium sinensis peel extract,
citrus reticulata fruit extract,
demineralized water, glycerin,
lactic acid), Honeysuckle (Lonicera
japonica), polylysine, Shagbark
Hickory (Carya ovata) Bark
Extract, steviol (Steviol
glycosides).
HPUS active ingredients Purpose
Equal volumes of each HPUS** ingredient in 12X, 30X, and 1LM
potencies unless otherwise noted.
Adenosinum cyclophosphoricum..............headache, runny nose
Adrenalinum ...........hay fever, swollen sinuses, lung congestion
Adrenocorticotrophin (30X) ............................congestion, cough
Allium cepa........................hay fever, sinus headache, sneezing
Alnus serrulata ............................................hay fever, bronchitis
Carduus benedictus .............................................tickling in nose
Cichorium intybus............................................fatigue, headache
Cortisone aceticum.............................allergic reaction, irritability
Dolichos pruriens.......................................sore throat, itchy skin
Euphrasia officinalis.....................discharge from eyes and nose
Galphimia glauca.................................... puffy eyelids, hay fever
Histaminum hydrochloricum...................coughing, itching throat
Juglans cinerea ..........................red eyes, sneezing, sore throat
Kali muriaticum......................................hoarseness, stuffy nose
Mucosa nasalis suis ..............sinus headache, nasal congestion
Nasturtium aquaticum .................... sensitivity to cigarette toxins
Natrum muriaticum...................................watery eyes, sneezing
Rhus tox .......................... dry cough, sneezing, swelling of nose
RNA..................................................................allergic reactions
Sabadilla.................................sore throat, runny nose, sneezing
Sassafras officinale ..............................minor breathing difficulty
**“HPUS” indicates the active ingredients are in the official
Homeopathic Pharmacopeia of the United States.
Questions? Call 866.298.2740
King Bio, Inc. • 3 Westside Drive
Asheville, NC 28806 USA
FDA Reg. #1053442
For latest product information
and instructions, visit
www.DrKings.com
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57955-0760-2 | 2022-01-28 | C162847 | 48780-1 | 9d75b9d0-8494-f424-e053-dadaa90a57ce | Regional Allergies Southern U.S. |
| 57955-8201-2 | 2020-07-09 | C162847 | 48780-1 | 9d75b9d0-8494-f424-e053-dadaa90a57ce | Regional Allergies Southern U.S. |
| 57955-8201-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-8494-f424-e053-dadaa90a57ce | Regional Allergies Southern U.S. |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57955-0760-2 | Regional Allergies Southern U.S. | 59 mL in 1 BOTTLE, SPRAY | LIQUID | 59 | 3 | |
| 57955-0760-2 | Regional Allergies Southern U.S. | 1 in 1 CARTON | LIQUID | 1 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 57955-0760 | REGIONAL ALLERGIES SOUTHERN U.S. (ADENOSINUM CYCLOPHOSPHORICUM, ADRENALINUM, ADRENOCORTICOTROPHIN, ALLIUM CEPA, ALNUS SERRULATA, CARDUUS BENEDICTUS, CICHORIUM INTYBUS, CORTISONE ACETICUM, DOLICHOS PRURIENS, EUPHRASIA OFFICINALIS, GALPHIMIA GLAUCA, HISTAMINUM HYDROCHLORICUM, JUGLANS CINEREA, KALI MURIATICUM, MUCOSA NASALIS SUIS, NASTURTIUM AQUATICUM, NATRUM MURIATICUM, RHUS TOX, RNA, SABADILLA, SASSAFRAS OFFICINALE) LIQUID [KING BIO INC.] | 3 | Legacy NDC, 2 package rows | 20200710_3697fcb7-4ab8-4ce4-a837-05f6a825f9ab.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ADENOSINE CYCLIC PHOSPHATE | ACTIVE INGREDIENT | E0399OZS9N | 1 | |
| ALNUS SERRULATA BARK | ACTIVE INGREDIENT | BQ5P19J9OL | 1 | |
| CENTAUREA BENEDICTA | ACTIVE INGREDIENT | 6L5ZL09795 | 1 | |
| CHICORY ROOT | ACTIVE INGREDIENT | 090CTY533N | 1 | |
| CORTICOTROPIN | ACTIVE INGREDIENT | K0U68Q2TXA | 1 | |
| CORTISONE ACETATE | ACTIVE INGREDIENT | 883WKN7W8X | 1 | |
| EPINEPHRINE | ACTIVE INGREDIENT | YKH834O4BH | 1 | |
| EUPHRASIA STRICTA | ACTIVE INGREDIENT | C9642I91WL | 1 | |
| GALPHIMIA GLAUCA FLOWERING TOP | ACTIVE INGREDIENT | 93PH5Q8M7E | 1 | |
| HISTAMINE DIHYDROCHLORIDE | ACTIVE INGREDIENT | 3POA0Q644U | 1 | |
| JUGLANS CINEREA BRANCH BARK/ROOT BARK | ACTIVE INGREDIENT | 48FZ1BHO18 | 1 | |
| MUCUNA PRURIENS FRUIT TRICHOME | ACTIVE INGREDIENT | 3E271BSI0C | 1 | |
| NASTURTIUM OFFICINALE | ACTIVE INGREDIENT | YH89GMV676 | 1 | |
| ONION | ACTIVE INGREDIENT | 492225Q21H | 1 | |
| POTASSIUM CHLORIDE | ACTIVE INGREDIENT | 660YQ98I10 | 1 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE INGREDIENT | J17GBZ5VGX | 1 | |
| SASSAFRAS ALBIDUM ROOT BARK | ACTIVE INGREDIENT | XC5UMP9I5F | 1 | |
| SCHOENOCAULON OFFICINALE SEED | ACTIVE INGREDIENT | 6NAF1689IO | 1 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| SUS SCROFA NASAL MUCOSA | ACTIVE INGREDIENT | ID3Z1X61WY | 1 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE INGREDIENT | 6IO182RP7A | 1 | |
| ADENOSINE CYCLIC 3',5'-PHOSPHATE | ACTIVE MOIETY | E0399OZS9N | 1 | |
| ALNUS SERRULATA BARK | ACTIVE MOIETY | BQ5P19J9OL | 1 | |
| CENTAUREA BENEDICTA | ACTIVE MOIETY | 6L5ZL09795 | 1 | |
| CHICORY ROOT | ACTIVE MOIETY | 090CTY533N | 1 | |
| CHLORIDE ION | ACTIVE MOIETY | Q32ZN48698 | 1 | |
| CORTICOTROPIN | ACTIVE MOIETY | K0U68Q2TXA | 1 | |
| CORTISONE | ACTIVE MOIETY | V27W9254FZ | 1 | |
| EPINEPHRINE | ACTIVE MOIETY | YKH834O4BH | 1 | |
| EUPHRASIA STRICTA | ACTIVE MOIETY | C9642I91WL | 1 | |
| GALPHIMIA GLAUCA FLOWERING TOP | ACTIVE MOIETY | 93PH5Q8M7E | 1 | |
| HISTAMINE | ACTIVE MOIETY | 820484N8I3 | 1 | |
| JUGLANS CINEREA BRANCH BARK/ROOT BARK | ACTIVE MOIETY | 48FZ1BHO18 | 1 | |
| MUCUNA PRURIENS FRUIT TRICHOME | ACTIVE MOIETY | 3E271BSI0C | 1 | |
| NASTURTIUM AQUATICUM | ACTIVE MOIETY | YH89GMV676 | 1 | |
| ONION | ACTIVE MOIETY | 492225Q21H | 1 | |
| POTASSIUM CATION | ACTIVE MOIETY | 295O53K152 | 1 | |
| SACCHAROMYCES CEREVISIAE RNA | ACTIVE MOIETY | J17GBZ5VGX | 1 | |
| SASSAFRAS ALBIDUM ROOT BARK | ACTIVE MOIETY | XC5UMP9I5F | 1 | |
| SCHOENOCAULON OFFICINALE SEED | ACTIVE MOIETY | 6NAF1689IO | 1 | |
| SUS SCROFA NASAL MUCOSA | ACTIVE MOIETY | ID3Z1X61WY | 1 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE MOIETY | 6IO182RP7A | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 57955-0760 | 57955-0760-2 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE / ORAL | 238 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GRANULE, FOR SUSPENSION / ORAL | 113 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INHALANT / RESPIRATORY (INHALATION) | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYRUP / ORAL | 722 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LOTION / TOPICAL | 0.85 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | LOTION / TOPICAL | 0.2 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / OPHTHALMIC | 0.03 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / SUBCUTANEOUS | 26 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, CHEWABLE / ORAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | EMULSION / TOPICAL | 0.11 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TROCHE / ORAL | 12 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SPRAY, METERED / NASAL | 0.06 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / ORAL | 315 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DROPS / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | OINTMENT / TOPICAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / IRRIGATION | 1 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SUSPENSION / ORAL | 400 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, FILM COATED / ORAL | 42 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | DOUCHE / VAGINAL | 0.07 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / TOPICAL | 17 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAMUSCULAR | 26 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / SUBLINGUAL | 24 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SYRUP / ORAL | 2 mg/1ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 38 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING / ORAL | 83 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 385 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAVENOUS | 2068 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM, EXTENDED RELEASE / TRANSDERMAL | 1.38 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRALESIONAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / BUCCAL | NA | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CREAM / TOPICAL | 0.25 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / AURICULAR (OTIC) | 0.2 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / IONTOPHORESIS | 0.2 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CAPSULE / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER / ORAL | 840 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / ORAL | 914 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / OPHTHALMIC | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAOCULAR | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY / NASAL | 9 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / IONTOPHORESIS | 0.02 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / RESPIRATORY (INHALATION) | 8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION / RESPIRATORY (INHALATION) | 0.03 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE, EXTENDED RELEASE / ORAL | 101 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION, EXTENDED RELEASE / ORAL | 140.8 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SUSPENSION / ORAL | 840 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / NASAL | 2.8 mg/1ml | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / ORAL | 1000 mg/15ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EFFERVESCENT / ORAL | 460 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SUSPENSION/ DROPS / ORAL | 19 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM / SUBLINGUAL | 10 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAMUSCULAR | 28 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | POWDER, FOR SUSPENSION / ORAL | 19 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SWAB / TOPICAL | 0.05 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / INTRAVENOUS | 0.2 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SOFT TISSUE | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| aa058110-d808-5fb5-e053-2a95a90a0737 | 3697fcb7-4ab8-4ce4-a837-05f6a825f9ab | 2020-07-09 | Warnings | aa058110-d808-5fb5-e053-2a95a90a0737 3697fcb7-4ab8-4ce4-a837-05f6a825f9ab |
Adverse event summaries are temporarily unavailable. Other product information remains available.